PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10418781-0	1999	Inhibition by ginsenosides Rb1 and Rg1 of cocaine-induced hyperactivity, conditioned place preference, and postsynaptic dopamine receptor supersensitivity in mice.	Cocaine	42-49	RB transcriptional corepressor 1	Mus musculus	27-30	
10418781-2	1999	Ginsenoside Rb1 (Rb1) and ginsenoside Rg1 (Rg1), prior to and during the cocaine treatment in mice, inhibited cocaine-induced hyperactivity and CPP.	Cocaine	110-117	RB transcriptional corepressor 1	Mus musculus	12-15	
10418781-2	1999	Ginsenoside Rb1 (Rb1) and ginsenoside Rg1 (Rg1), prior to and during the cocaine treatment in mice, inhibited cocaine-induced hyperactivity and CPP.	Cocaine	110-117	RB transcriptional corepressor 1	Mus musculus	17-20	
10418781-6	1999	Therefore, it is presumed that Rb1 and Rg1 modulate DA activity induced by cocaine at the presynaptic DA receptors, and this modulation results in the inhibition of postsynaptic dopaminergic activation.	Cocaine	75-82	RB transcriptional corepressor 1	Mus musculus	31-34	
10418781-8	1999	The inhibition by Rb1 and Rg1 of cocaine-induced hyperactivity and CPP may be closely related with the inhibition of dopaminergic activation induced by cocaine at the presynaptic DA receptors.	Cocaine	33-40	RB transcriptional corepressor 1	Mus musculus	18-21	
10418781-8	1999	The inhibition by Rb1 and Rg1 of cocaine-induced hyperactivity and CPP may be closely related with the inhibition of dopaminergic activation induced by cocaine at the presynaptic DA receptors.	Cocaine	152-159	RB transcriptional corepressor 1	Mus musculus	18-21